ALAMEDA

Bridging the Early Diagnosis and Treatment Gap of Brain Diseases via Smart, Connected, Proactive and Evidence-based Technological Interventions

 ALAMEDA is a project funded by the European Commission
under the HORIZON 2020 Programme.


Lowering treatment costs for brain disorders through AI.

In healthcare, the cost of treating brain disorders accounts for a significant percentage of total treatment costs. In Europe, the budget for treating brain disorders alone far surpasses the combined budget for other diseases.

Utilising cutting-edge Artificial Intelligence, the EU-funded ALAMEDA project could greatly reduce the cost of treating these conditions by enabling personalised care and improved treatments for major brain disorders.

The goal is to demonstrate AI-enabled prediction, prevention and intervention, making the treatment of disorders such as Parkinson's, multiple sclerosis and strokes more affordable and easing the burden on healthcare systems across Europe.

 


Duration: 1 January 2021 - 31 December 2023
Grant Agreement: 101017558
Overall Budget (€): 6053812,50

Partners

Info

Pluribus One S.r.l.

Via Bellini 9, 09128, Cagliari (CA)

info[at]pluribus-one.it

PEC: pluribus-one[at]pec.pluribus-one.it

 

Legal entity

Share capital: € 10008

VAT no.: 03621820921

R.E.A.: Cagliari 285352


 

University of Cagliari

  Pluribus One is a spin-off

  of the Department of

  Electrical and Electronic Engineering

  University of Cagliari, Italy

 

© 2021 Pluribus One s.r.l. All Rights Reserved.